Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Feb. 28, 2023
Feb. 28, 2022
Feb. 28, 2023
Feb. 28, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)        
Revenue $ 35,015 $ 30,650 $ 136,491 $ 44,530
Cost of goods sold (2,958) (6,387) (18,753) (11,957)
Gross profit 32,057 24,263 117,738 32,573
Expenses        
Research and development 696,178 275,686 1,525,667 734,395
General and administrative 646,517 1,197,250 1,672,015 2,750,333
Total operating expenses 1,342,695 1,472,936 3,197,682 3,484,728
Net Loss (1,310,638) (1,448,673) (3,079,944) (3,452,155)
Net loss attributable to:        
Common shareholders (1,298,131) (1,425,776) (3,054,075) (3,418,933)
Non-controlling interest $ (12,507) $ (22,897) $ (25,869) $ (33,222)
Basic and diluted loss per share $ (0.22) $ (0.25) $ (0.51) $ (0.59)
Weighted average shares outstanding        
- Basic and diluted 5,950,998 5,911,123 5,950,998 5,818,401